Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 592

1.

Hepatitic graft-versus-host disease after hematopoietic stem cell transplantation: clinicopathologic features and prognostic implication.

Ma SY, Au WY, Ng IO, Lie AK, Leung AY, Liang R, Lau GK, Kwong YL.

Transplantation. 2004 Apr 27;77(8):1252-9.

PMID:
15114094
2.

Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion.

Akpek G, Boitnott JK, Lee LA, Hallick JP, Torbenson M, Jacobsohn DA, Arai S, Anders V, Vogelsang GB.

Blood. 2002 Dec 1;100(12):3903-7. Epub 2002 Jul 18.

3.

Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.

Ma SY, Au WY, Lie AK, Ng IO, Leung AY, Tse EW, Liang RH, Lau GK, Kwong YL.

Bone Marrow Transplant. 2004 Jul;34(1):57-61.

PMID:
15156162
4.

Role of liver biopsy in the management of liver dysfunction after hematopoietic stem-cell transplantation in a hepatitis B virus-prevalent patient population.

Ma SY, Au WY, Ng IO, Lie AK, Leung AY, Liang RH, Lau GK, Kwong YL.

Transplantation. 2003 Jul 15;76(1):169-76.

PMID:
12865805
5.

[Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].

Chen H, Huang XJ, Liu KY, Xu LP, Wang H, Liu DH, Lu J, Lu DP.

Zhonghua Yi Xue Za Zhi. 2005 Nov 16;85(43):3062-6. Chinese.

PMID:
16324408
6.

Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.

El-Sayed MH, El-Haddad A, Fahmy OA, Salama II, Mahmoud HK.

Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1347-54.

PMID:
15618844
7.

Kinetics of bilirubin and liver enzymes is useful for predicting of liver graft-versus-host disease.

Krejci M, Kamelander J, Pospisil Z, Mayer J.

Neoplasma. 2012;59(3):264-8. doi: 10.4149/neo_2012_034.

PMID:
22296496
8.

Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation.

Fujii N, Takenaka K, Shinagawa K, Ikeda K, Maeda Y, Sunami K, Hiramatsu Y, Matsuo K, Ishimaru F, Niiya K, Yoshino T, Hirabayashi N, Harada M.

Bone Marrow Transplant. 2001 May;27(9):1007-10.

9.

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.

Ruutu T, Eriksson B, Remes K, Juvonen E, Volin L, Remberger M, Parkkali T, Hägglund H, Ringdén O; Nordic Bone Marrow Transplantation Group.

Blood. 2002 Sep 15;100(6):1977-83.

10.

[Study on the damage of liver in patients with SARS].

Guan YJ, Tang XP, Yin CB, Yi ZQ.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 May;16(5):267-70. Chinese.

PMID:
15132787
11.

Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.

Duarte RF, Delgado J, Shaw BE, Wrench DJ, Ethell M, Patch D, Dhillon AP, Mackinnon S, Potter MN, Quaglia AF.

Biol Blood Marrow Transplant. 2005 Oct;11(10):805-13.

13.

Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.

Strasser SI, Shulman HM, Flowers ME, Reddy R, Margolis DA, Prumbaum M, Seropian SE, McDonald GB.

Hepatology. 2000 Dec;32(6):1265-71.

PMID:
11093733
14.

[Analysis of acute liver "graft-versus-host disease" following allogeneic myeloablative stem cell transplant].

Doki N, Saito Y, Hatsumi N, Irisawa H, Sakura T, Miyawaki S.

Rinsho Ketsueki. 2004 Jan;45(1):57-60. Japanese.

PMID:
14999935
15.

Chronic graft-versus-host disease after hematopoietic cell transplantation presenting as an acute hepatitis.

Malik AH, Collins RH Jr, Saboorian MH, Lee WM.

Am J Gastroenterol. 2001 Feb;96(2):588-90.

PMID:
11232714
16.

Hyperbilirubinemia after hematopoietic stem cell transplantation: comparison of clinical and pathologic findings in 41 autopsied cases.

Kagoya Y, Takahashi T, Nannya Y, Shinozaki A, Ota S, Fukayama M, Kurokawa M.

Clin Transplant. 2011 Sep-Oct;25(5):E552-7. doi: 10.1111/j.1399-0012.2011.01498.x. Epub 2011 Sep 15.

PMID:
21919962
17.

Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Lee KH, Choi SJ, Lee JH, Lee JS, Kim WK, Lee KB, Sohn SK, Kim JG, Kim DH, Seol M, Lee YS, Lee JH.

Haematologica. 2005 Jul;90(7):939-48.

18.

Hepatitic pattern of graft versus host disease in children.

Melín-Aldana H, Thormann K, Duerst R, Kletzel M, Jacobsohn DA.

Pediatr Blood Cancer. 2007 Oct 15;49(5):727-30.

PMID:
17066458
19.

Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation.

Saunders MD, Shulman HM, Murakami CS, Chauncey TR, Bensinger WI, McDonald GB.

Am J Surg Pathol. 2000 Jul;24(7):1004-8.

PMID:
10895823
20.

Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide.

Mayer J, Krejci M, Pospisil Z, Doubek M, Janikova A, Zackova D, Racil Z, Smardova L, Navratil M, Kamelander J.

Exp Hematol. 2009 Jun;37(6):767-73. doi: 10.1016/j.exphem.2009.03.006.

PMID:
19463776

Supplemental Content

Support Center